Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-20-061714

Chief Executive Officer sold 10,000 shares at an average $151.40 ($1,513,953)

  • Chief Executive Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Saxonov Serge · Chief Executive Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-01 Exercise or conversion : show line 1 in the form +6,250 $1.20 $7,500 973,431 D
2020-12-01 Exercise or conversion : show line 2 in the form +3,750 $5.04 $18,900 977,181 D
2020-12-01 Sale : show line 3 in the form −3,004 $150.01 $450,620 974,177 D
2020-12-01 Sale : show line 4 in the form −3,398 $151.02 $513,174 970,779 D
2020-12-01 Sale : show line 5 in the form −1,091 $151.92 $165,749 969,688 D
2020-12-01 Sale : show line 6 in the form −2,174 $153.26 $333,179 967,514 D
2020-12-01 Sale : show line 7 in the form −333 $153.84 $51,230 967,181 D
Open-market sales · 10,000 sh · avg $151.40 · $1,513,953

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-12-01 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −6,250 $1.20 2027-10-18 6,250 109,860 D
2020-12-01 Exercise or conversion : show line 9 in the form Stock Option (right to buy) −3,750 $5.04 2028-11-02 3,750 124,515 D
Loading xslF345X03/doc4.xml…